Senti Biosciences is trading at $0.39 (up 5.1%) in pre-market action, extending its gains from the previous session as the biotech sector continues to recover.
- The stock is building on a 10.5% rally from August 03, 2026, which was driven by broad risk-on sentiment and strength in beaten-down biotech names.
- Today’s upward movement appears to be a continuation of that momentum, as there are currently no new company-specific catalysts reported.